SEKUL; RENATE

Patent Applications and Registrations

Patent applications and USPTO patent grants for SEKUL; RENATE.The latest application filed is for "ns2b as marker for zika virus infections".

Company Profile

1.36.31

SEKUL; RENATE - SCHRIESHEIM DE
Sekul; Renate - Ladenburg DE
Sekul; Renate - Landenburg DE
Sekul; Renate - DE DE
Sekul; Renate - D-68526 Ladenburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ns2b As Marker For Zika Virus Infections App 20200325183 - JAENISCH; THOMAS ; et al.	2020-10-15
Ligands For Antibody And Fc-fusion Protein Purification By Affinity Chromotography Iv App 20170334948 - BITTERMANN; Holger ; et al.	2017-11-23
Ligands for antibody and Fc-fusion protein purification by affinity chromotography IV Grant 9,745,339 - Bittermann , et al. August 29, 2	2017-08-29
LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY App 20170152288 - BITTERMANN; Holger ; et al.	2017-06-01
Ligands For Antibody And Fc-fusion Protein Purification By Affinity Chromotography Iv App 20160009760 - BITTERMANN; Holger ; et al.	2016-01-14
3-arylamino pyridine derivatives Grant 8,841,459 - Deppe , et al. September 23, 2	2014-09-23
3-Arylamino Pyridine Derivatives App 20140051686 - Abel; Ulrich ; et al.	2014-02-20
3-arylamino pyridine derivatives Grant 8,524,911 - Abel , et al. September 3, 2	2013-09-03
LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY App 20130131321 - Bittermann; Holger ; et al.	2013-05-23
3-Arylamino Pyridine Derivatives App 20120295889 - Abel; Ulrich ; et al.	2012-11-22
3-arylamino pyridine derivatives Grant 8,198,457 - Abel , et al. June 12, 2	2012-06-12
3-Arylamino Pyridine Derivatives App 20110224192 - Abel; Ulrich ; et al.	2011-09-15
Surface for the immobilization of ligands Grant 7,955,638 - Dickopf , et al. June 7, 2	2011-06-07
3-arylamino pyridine derivatives Grant 7,956,191 - Abel , et al. June 7, 2	2011-06-07
Multimeric apoprotein agonists Grant 7,566,695 - Dasseux , et al. July 28, 2	2009-07-28
3-Arylamino pyridine derivatives App 20090093462 - Abel; Ulricn ; et al.	2009-04-09
Surface for the immobilization of ligands App 20080167196 - Dickopf; Stefan ; et al.	2008-07-10
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20080058270 - Dasseux; Jean-Louis ; et al.	2008-03-06
Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder App 20080050351 - Dasseux; Jean-Louis ; et al.	2008-02-28
Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,312,190 - Dasseux , et al. December 25, 2	2007-12-25
Multimeric Apo A-I agonist compounds Grant 7,307,058 - Dasseux , et al. December 11, 2	2007-12-11
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,273,848 - Dasseux , et al. September 25, 2	2007-09-25
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,250,407 - Dasseux , et al. July 31, 2	2007-07-31
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,211,565 - Dasseux , et al. May 1, 2	2007-05-01
Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders Grant 7,189,689 - Dasseux , et al. March 13, 2	2007-03-13
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,157,425 - Dasseux , et al. January 2, 2	2007-01-02
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20060252694 - Dasseux; Jean-Louis ; et al.	2006-11-09
Multimeric Apo A-I agonist compounds App 20050215467 - Dasseux, Jean-Louis ; et al.	2005-09-29
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20050203284 - Dasseux, Jean-Louis ; et al.	2005-09-15
Bioactive sensors App 20050153357 - Eichler, Jutta ; et al.	2005-07-14
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20050148513 - Dasseux, Jean-Louis ; et al.	2005-07-07
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,900,177 - Dasseux , et al. May 31, 2	2005-05-31
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20050080013 - Dasseux, Jean-Louis ; et al.	2005-04-14
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,844,327 - Dasseux , et al. January 18, 2	2005-01-18
Screening method using solid supports modified with self-assembled monolayers App 20040248111 - Metz, Gunther ; et al.	2004-12-09
Surface for the immobilization of ligands App 20040235146 - Dickopf, Stefan ; et al.	2004-11-25
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20040198662 - Dasseux, Jean-Louis ; et al.	2004-10-07
Multimeric Apo A-I agonist compounds App 20040181034 - Dasseux, Jean-Louis ; et al.	2004-09-16
Multimeric Apoa-I agonist compounds Grant 6,753,313 - Dasseux , et al. June 22, 2	2004-06-22
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,734,169 - Dasseux , et al. May 11, 2	2004-05-11
Low affinity screening method App 20040082079 - Besenbruch, Ralf ; et al.	2004-04-29
Multimeric Apo A-I agonist compounds Grant 6,716,816 - Dasseux , et al. April 6, 2	2004-04-06
Apolipoprotein A-i Agonists And Their Use To Treat Dyslipidemic Disorders App 20040029807 - Dasseux, Jean-Louis ; et al.	2004-02-12
Surface for the immobilization of ligands App 20040023366 - Dickopf, Stefan ; et al.	2004-02-05
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20030208059 - Dasseux, Jean-Louis ; et al.	2003-11-06
Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders App 20030203842 - Dasseux, Jean-Louis ; et al.	2003-10-30
Method of treating dyslipidemia Grant 6,630,450 - Dasseux , et al. October 7, 2	2003-10-07
Branched multimeric Apo A-I agonist compounds Grant 6,602,854 - Dasseux , et al. August 5, 2	2003-08-05
Apolipoprotein A-I agonist compounds Grant 6,573,239 - Dasseux , et al. June 3, 2	2003-06-03
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20030060604 - Dasseux, Jean-Louis ; et al.	2003-03-27
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20030008827 - Dasseux, Jean-Louis ; et al.	2003-01-09
Bioactive sensors App 20020127577 - Eichler, Jutta ; et al.	2002-09-12
Lipid complexes of APO A-1 agonist compounds Grant 6,376,464 - Dasseux , et al. April 23, 2	2002-04-23
Method of treating septic shock Grant 6,329,341 - Dasseux , et al. December 11, 2	2001-12-11
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,265,377 - Dasseux , et al. July 24, 2	2001-07-24
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,046,166 - Dasseux , et al. April 4, 2	2000-04-04
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,037,323 - Dasseux , et al. March 14, 2	2000-03-14
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,004,925 - Dasseux , et al. December 21, 1	1999-12-21